This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Qed Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Carl Dambkowski
Introduction
Carl Dambkowski is a notable inventor based in San Mateo, California. He has made significant contributions to the field of medicine, particularly in the treatment of cholangiocarcinoma. His innovative approach has the potential to improve patient outcomes in this challenging area of oncology.
Latest Patents
Dambkowski holds a patent for "Methods of treating cholangiocarcinoma." This patent outlines methods for treating advanced or metastatic cholangiocarcinoma in patients by administering infigratinib or a pharmaceutically acceptable salt thereof. This treatment is specifically designed for patients who have experienced progression of the disease after previous therapies. He has 1 patent to his name.
Career Highlights
Carl Dambkowski is currently associated with QED Therapeutics, Inc., where he continues to work on innovative solutions for cancer treatment. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Dambkowski has worked alongside talented colleagues such as Riccardo Panicucci and Michael Monteith. Their combined expertise fosters a collaborative environment that enhances the development of new therapeutic methods.
Conclusion
Carl Dambkowski's work in the treatment of cholangiocarcinoma exemplifies the impact of innovation in medicine. His contributions are paving the way for improved therapies and better patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile